News Analysis

Most Recent

Is the FDA's drug review process breaking down?

By | December 20, 2000

Since 1997 the US FDA has banned use of 11 prescription drugs because of serious side effects. The FDA says it's not the drug approval process but inappropriate prescribing that is responsible.

0 Comments

MPs say 'yes' to stem cell research

By | December 20, 2000

British Members of Parliament have voted in favour of allowing therapeutic cloning.

0 Comments

Craig Venter is 'Scientist of the Year'

By | December 18, 2000

magazine's 'Person of the Year'.

0 Comments

Stem cell decision time for the UK

By | December 18, 2000

The British parliament is to vote on Tuesday 19 December on whether to allow research into stem cell technology to be extended beyond its current boundaries.

0 Comments

- or is it the other way around?

By | December 14, 2000

Donald Kennedy.

0 Comments

HOUSTON A variety of motives are behind several recent drug company announcements of donations of HIV/AIDS drugs to African countries. Certainly, something needs to be done to control existing cases of HIV/AIDS, in addition to the lifestyle changes that would reduce the number of new AIDS cases. By the end of this year, 36.1 million people will be living with HIV or AIDS, according to the Joint United Nations Program on HIV/AIDS (UNAIDS) and the World Health Organization (WHO).WHO and UNAIDS res

0 Comments

Why did the chicken cross the DNA?

By | December 6, 2000

Advances in transgenics and drug production are foreseen using chicken eggs, says the Roslin Institute. But why chickens?

0 Comments

Banking on genes

By | December 4, 2000

Various high-profile genetic projects around the world are pushing the barriers of research. But are they trespassing on human rights?

0 Comments

Drug metabolites can now be patented

By | November 29, 2000

HOUSTON Bristol-Myers Squibb Company unveiled both a scientific achievement and a patent strategy that, if used by other drug companies, could delay introduction of cheaper generic versions of hundreds of patented drugs. Typically, after patents expire and generic versions of a drug become available, most drugs lose up to 80% of sales during the first year they face generic competition, according to Barbara Ryan, a drug industry analyst with Deutsche Banc Alex Brown. US patents on drugs with sal

0 Comments

Potential AIDS epidemic in Eastern Europe

By | November 29, 2000

Experts fear that Eastern Europe could experience an AIDS epidemic similar to that seen in Africa.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
PITTCON
PITTCON
Life Technologies